Clinuvel considers Nasdaq listing and ASX delisting
Clinuvel Pharmaceuticals (ASX:CUV) announced its board is considering changing its holding structure to list on the Nasdaq and delist from the ASX.

Jon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
Clinuvel Pharmaceuticals (ASX:CUV) announced its board is considering changing its holding structure to list on the Nasdaq and delist from the ASX.
StarkWare says it completed what it describes as the first quantum-resistant Bitcoin (CRYPTO:BTC) transaction on mainnet.
US spot Bitcoin ETFs recorded US$3.03 billion in August inflows after seven straight positive trading days.
Dallas Fed economists estimate tokenised deposits could reduce US banks’ capacity by about US$700 billion.
A survey found 77% of Americans see cryptocurrency in workplace retirement plans as risky, including 46% who call it very risky.
Mineral Resources (ASX:MIN) reported a record statutory net profit after tax of $1.2 billion for the full year ended June 30.
NVIDIA (NASDAQ:NVDA) reported second quarter fiscal 2027 revenue of $96.2 billion, up 106% year over year, as Data Center revenue reached $89 billion and drove the company’s latest quarterly results.
Salesforce (NYSE:CRM) reported second-quarter fiscal 2027 revenue of $11.3 billion, up 11% year over year and in constant currency for the quarter ended July 31, 2026.
Photronics (NASDAQ:PLAB) reported a 2.7% year-over-year revenue increase to $216.0 million for the third quarter of 2026.
Kohl’s (NYSE:KSS) reported second-quarter 2026 net sales of $3.3 billion, down 0.9% year over year, while comparable sales also declined 0.9%.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy